Parse Biosciences

Parse Biosciences is a global life sciences company whos mission is to accelerate progress in human health and scientific researc. Empowering researches to perform single cell sequencing with unprecedented scale and ease, its pioneering approach has enabled groundbreaking discoveries in cancer treatment, tissue repair, stem cell therapy, kidney and liver disease, brain development, and the immune system.

Content by Parse Biosciences

parse_logo

Vanderbilt Selects Parse Biosciences GigaLab to Generate Atlas of Early Neutralizing Antibodies to Measles, Mumps, and Rubella

Parse Biosciences | | 1 min read

Pioneering Cancer Plasticity Atlas will help Predict Response to Cancer Therapies

Parse Biosciences | | 2 min read

Page 1 of 1 - 2 Total Items

July Digest 2025

July 2025, Issue 1

What Causes an Earworm?

Memory-enhancing neural networks may also drive involuntary musical loops in the brain.

View this Issue

Research Resources

Podcasts

Webinars

Videos

Infographics

eBooks

Explore synthetic DNA’s many applications in cancer research

Weaving the Fabric of Cancer Research with Synthetic DNA

Modern DNA synthesis platforms empower researchers to explore the molecular world, from next-generation sequencing to cell and gene therapy development.

Illustrated plasmids in bright fluorescent colors

Enhancing Elution of Plasmid DNA

An improved chromatography membrane elution method helps scientists achieve higher yields of pure plasmid DNA.

An illustration of green lentiviral particles.

Maximizing Lentivirus Recovery

By fine-tuning polishing conditions, scientists attain high titers of infectious lentiviral particles during purification.

Explore new strategies for improving plasmid DNA manufacturing workflows.

Overcoming Obstacles in Plasmid DNA Manufacturing

Discover a scalable and flexible GMP-compliant workflow for producing plasmid DNA.

Products

Product News

Introducing the iQue 5 HTS Platform: Empowering Scientists with Unbeatable Speed and Flexibility for High Throughput Screening by Cytometry

New fluidics and clog detection systems further simplify operation and reduce instrument downtime

parse_logo

Vanderbilt Selects Parse Biosciences GigaLab to Generate Atlas of Early Neutralizing Antibodies to Measles, Mumps, and Rubella

Researchers aim to discover dominant subtypes of plasmablasts initiating from the MMR vaccine in order to develop neutralizing antibody candidate therapies

shiftbioscience

Shift Bioscience proposes improved ranking system for virtual cell models to accelerate gene target discovery

Study identifies new metrics to enhance scRNA-seq based virtual cell modelling

BRANDTECH Scientific Launches New Website for VACUU·LAN® Lab Vacuum Systems

Redefining Lab Vacuum with Efficiency, Flexibility, and Sustainability